Itama Ranoraya PT

Itama Ranoraya PT Financial Leverage

The Financial Leverage (Equity Multiplier) of Itama Ranoraya PT (IRRA.JK) as of Oct 19, 2026 is 4.21. In the previous year, Financial Leverage (Equity Multiplier) was 3.24 — a change of 30.02% (higher).

Financial Leverage

4.21

YoY

30.02%

Last updated:

Financial Leverage (Equity Multiplier) of Itama Ranoraya PT is 2025 4.21 . Financial Leverage (Equity Multiplier) of Itama Ranoraya PT was 2024 3.24 . It decreases by 30.02% higher compared to the previous year.

The Itama Ranoraya PT Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
2.04 IDR
Jan 1, 2019
1.38 IDR
Jan 1, 2020
2.21 IDR
Jan 1, 2021
1.56 IDR
Jan 1, 2022
1.52 IDR
Jan 1, 2023
2.31 IDR
Jan 1, 2024
3.24 IDR
Jan 1, 2025
4.21 IDR
The Itama Ranoraya PT Financial Leverage history
YEARFinancial LeverageYoY
4.21+30.02%
3.24+40.43%
2.31+52.08%
1.52-2.66%
1.56-29.48%
2.21+59.62%
1.38-32.32%
2.04-28.98%
2.88+14.10%
2.52—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Itama Ranoraya PT Stock analysis

What does Itama Ranoraya PT do? Itama Ranoraya PT, trading as IRRA.JK, is a medical devices distributor headquartered in Jakarta Timur, Indonesia. The company employs 209 full-time staff and went public on October 15, 2019. It operates in the wholesale trade of laboratory equipment, pharmaceutical equipment, and human medical devices. Its product segments include non-electromedical sterile medical devices, in-vitro diagnostics, electromedical sterile medical devices, and other products. Key business areas cover in-vitro diagnostics, medical imaging, surgical instruments, critical care, blood banking, cardiovascular care, neurology, oncology, urology, and maternal and neonatal care. Product brands include Oneject, Abbott, Terumo, Becton Dickinson, HMD, Vestfrost, Balmed, iGene, AVIMAC, and HemoCue. Itama Ranoraya PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Itama Ranoraya PT stock

Financial Leverage (Equity Multiplier) of Itama Ranoraya PT is 4.21 in 2025.

Financial Leverage (Equity Multiplier) of Itama Ranoraya PT changed from 3.24 to 4.21, representing a 30.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Itama Ranoraya PT since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Itama Ranoraya PT with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Itama Ranoraya PT

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Itama Ranoraya PT